TABLE 2.
Kinetic parameters for all n-3 and n-6 PUFA whole-body synthesis-secretion following infusion of 2H5-ALA, 13C22-DHA, 13C18-LNA, and 13C22-DPAn-6 over 3 h
Tracer Source | Fatty Acid | Maximal Rate of Synthesis (Smax, nmol/min) | Synthesis-Secretion Coefficient (k1,PUFA, ml/min) | Daily Synthesis-Secretion Rate (nmol/day) | Turnover (FPUFA, %/day) | Half-Life (t1/2,PUFA,days) |
n-3 PUFA pathway | ||||||
ALA | ALA | 0.24 ± 0.04a | 0.37 ± 0.05a | 1971 ± 393a | 12.8 ± 2.1ab | 0.068 ± 0.013ab |
SDA | 0.003 ± 0.001de | 0.004 ± 0.001de | 21.8 ± 4.3de | 8.4 ± 2.5ab | 0.16 ± 0.05ab | |
20:3n-3 | 0.012 ± 0.004cd | 0.019 ± 0.007cd | 92.8 ± 24.3bcd | 8.7 ± 2.8ab | 0.19 ± 0.07ab | |
20:4n-3 | 0.021 ± 0.007bc | 0.035 ± 0.012bc | 203 ± 75bc | 37.3 ± 12.8a | 0.035 ± 0.009a | |
EPA | 0.040 ± 0.007b | 0.068 ± 0.013b | 369 ± 86b | 3.9 ± 0.9b | 0.38 ± 0.15b | |
DPAn-3 | 0.043 ± 0.009b | 0.072 ± 0.017b | 408 ± 116b | 4.0 ± 1.1b | 0.89 ± 0.67b | |
TPAn-3 | 0.001 ± 0.0001e | 0.001 ± 0.0001e | 7.6 ± 1.4e | 5.1 ± 1.1b | 0.34 ± 0.20b | |
THA | 0.004 ± 0.001d | 0.007 ± 0.002de | 42.1 ± 12.9cde | 3.8 ± 1.0b | 0.78 ± 0.50b | |
DHA | 0.011 ± 0.003cd | 0.017 ± 0.005cd | 94 ± 31.4bcd | 0.067 ± 0.023c | 30.4 ± 11.6c | |
DHA | EPA | 0.006 ± 0.001## | 0.13 ± 0.03## | 373 ± 121 | 4.3 ± 1.6 | 0.31 ± 0.07 |
DHA | 0.18 ± 0.03## | 4.2 ± 0.9## | 11780 ± 3147## | 8.9 ± 2.4## | 0.14 ± 0.04## | |
n-6 PUFA pathway | ||||||
LNA | LNA | 0.427 ± 0.044a,* | 0.137 ± 0.018a,* | 28695 ± 4715a,* | 2.6 ± 0.4a,* | 0.31 ± 0.04a,* |
GLA | 0.005 ± 0.001bc,* | 0.002 ± 0.0003bc,* | 343 ± 72bc,* | 2.7 ± 1.0ab,* | 0.92 ± 0.59ab,* | |
20:2n-6 | 0.0014 ± 0.0003cd,* | 0.0005 ± 0.0001cd,* | 98 ± 25cd | 0.67 ± 0.22b,* | 2.8 ± 1.1b,* | |
DGLA | 0.009 ± 0.003bc,* | 0.003 ± 0.001bc,* | 446 ± 130bc | 1.7 ± 0.4ab,* | 0.73 ± 0.23ab,* | |
ARA | 0.011 ± 0.005b,* | 0.003 ± 0.001b,* | 610 ± 205b | 0.056 ± 0.018c,* | 23 ± 7c,* | |
22:4n-6 | 0.017 ± 0.01b,* | 0.005 ± 0.003b,* | 833 ± 494b | 2.0 ± 1.1ab | 1.2 ± 0.5ab | |
TTA | n.d. | n.d. | n.d. | n.d. | n.d. | |
TPAn-6 | n.d. | n.d. | n.d. | n.d. | n.d. | |
DPAn-6&& | 0.0004 ± 0.0001d,* | 0.0001 ± 0.00005d,* | 29 ± 11d,* | 0.067 ± 0.021c | 14.3 ± 6.5c | |
DPAn-6 | ARA | n.d. | n.d. | n.d. | n.d. | n.d. |
DPAn-6 | 0.013 ± 0.007#,* | 1.6 ± 0.6#,* | 1690 ± 609#,* | 6.2 ± 2.6## | 0.31 ± 0.10## |
Different superscript letters represent statistically different kinetic values between fatty acids and within a kinetic measure for each individual n-3 and n-6 PUFA biosynthetic pathway. Values are expressed as mean ± SEM, n = 8. DGLA, dihomo-γ-linolenic acid.
Represents significantly different kinetic values for an individual PUFA derived from DHA versus ALA, and DPAn-6 versus LNA precursors, P < 0.05.
*Represents significantly different kinetic values compared with n-3 PUFA biosynthetic pathway homologs for all n-6 PUFAs by t-test, P < 0.05.
n = 3 for DPAn-6 kinetic parameters from LNA.